Wells Fargo & Company Cuts Crescent Capital BDC (NASDAQ:CCAP) Price Target to $18.00
Crescent Capital BDC (NASDAQ:CCAP – Free Report) had its price objective decreased by Wells Fargo & Company from $19.00 to $18.00 in a research note issued to investors on Friday morning,Benzinga reports. Wells Fargo & Company currently has an equal weight rating on the stock. Separately, Keefe, Bruyette & Woods lifted their price objective on […]
Crescent Capital BDC (NASDAQ:CCAP – Free Report) had its price objective decreased by Wells Fargo & Company from $19.00 to $18.00 in a research note issued to investors on Friday morning,Benzinga reports. Wells Fargo & Company currently has an equal weight rating on the stock. Separately, Keefe, Bruyette & Woods lifted their price objective on […]
